Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment)Of Menstrual Migraine

NCT00904098 is registered in ClinicalTrials.gov with Endo USA Inc., a Keenova Therapeutics Company as lead sponsor.

NCT NCT00904098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00904098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness And Safety Of Frovatriptan For The Management (Acute Treatment)Of Menstrual Migraine
Lead sponsor
Endo USA Inc., a Keenova Therapeutics Company
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
February 28, 2006
Enrollment
192 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

menstrual migraine (mm) headaches